FAQ/Help |
Calendar |
Search |
Today's Posts |
|
![]() |
#1 | ||
|
|||
Member
|
A few months ago a promising treatment was said to be in development. I haven't heard much on it since then, has anyone? Maybe something to bring to our neurologists and ask...
http://www.pharmaceutical-technology...atment-4665940
__________________
Diagnosis: Idiopathic Small Fiber Neuropathy (Statin Induced) • R-Lipoic Acid: 100mg - 300mg Daily • Acetyl-L Carnitine: 1500mg Daily • Vitamin B12: 1000 mcg Daily • Magnesium 500mg Daily • Grape Seed Extract 200mg Daily • Benfotiamine 300mg daily |
||
![]() |
![]() |
![]() |
#2 | |||
|
||||
Wisest Elder Ever
|
This is very interesting. However, I cannot find anything about it at the FDA or Orange Book. I suspect they will have a while yet to do that legal paperwork and perhaps trials.
__________________
All truths are easy to understand once they are discovered; the point is to discover them.-- Galileo Galilei ************************************ . Weezie looking at petunias 8.25.2017 **************************** These forums are for mutual support and information sharing only. The forums are not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Always consult your doctor before trying anything you read here.
|
|||
![]() |
![]() |
![]() |
#3 | |||
|
||||
Member
|
Just reading between the lines of the article it is likely that an IND has been filed and no holds have been placed by the FDA - especially if Merck Sorono has formed a partnership with this biotech company. It's not in the FDA Orange book because these in-licensing agreements tend to happen during the Phase II clinical trial stage. I'll try to check on this at work, but I would imagine it will be a while before we see Phase III results.
|
|||
![]() |
![]() |
![]() |
#4 | ||
|
|||
Member
|
Quote:
![]()
__________________
Diagnosis: Idiopathic Small Fiber Neuropathy (Statin Induced) • R-Lipoic Acid: 100mg - 300mg Daily • Acetyl-L Carnitine: 1500mg Daily • Vitamin B12: 1000 mcg Daily • Magnesium 500mg Daily • Grape Seed Extract 200mg Daily • Benfotiamine 300mg daily |
||
![]() |
![]() |
"Thanks for this!" says: | Cliffman (12-02-2015), madisongrrl (12-02-2015) |
![]() |
#5 | |||
|
||||
Member
|
Quote:
http://neurotalk.psychcentral.com/sh...12#post1186212
__________________
|
|||
![]() |
![]() |
"Thanks for this!" says: | Cliffman (12-02-2015) |
![]() |
#6 | ||
|
|||
Member
|
So did anybody find something in clinicaltrail.gov?This would be interesting to follow.
But i agree this is very interesting so there are now 2 drugs being developt I also cant find the website from "Relief Therapeutics" A explenation of what phases in clinical trails mean http://biopharma.merckgroup.com/en/r...al_trials.html European clinical trails https://www.clinicaltrialsregister.e...opathy&page=19 |
||
![]() |
![]() |
Reply |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
I never heard of Neuropathy | Peripheral Neuropathy | |||
Has anyone heard of this treatment | Peripheral Neuropathy | |||
Interferon Alfa-n3 | Multiple Sclerosis | |||
Has anybody with SM heard of treatment with Low Dose Naltrexone | Arnold Chiari Malformation & Syringomyelia |